Shanghai OPM Biosciences Co., Ltd. (SHA:688293)
China
· Delayed Price · Currency is CNY 48.64
-0.33 (-0.67%)
At close: Mar 9, 2026
Shanghai OPM Biosciences Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Net Income | - | 21.05 | 54.04 | 105.37 | 60.39 | Upgrade
|
| Depreciation & Amortization | - | 45.68 | 36.83 | 33.85 | 28.19 | Upgrade
|
| Other Amortization | - | 12.39 | 5.88 | 5.17 | 4.07 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -0.09 | - | -0.29 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 7.51 | 0.02 | 0 | 0.02 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -18.25 | -14.59 | -5.81 | -4.18 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 6.92 | 6.42 | 4.76 | 0.31 | Upgrade
|
| Other Operating Activities | - | -0.6 | 1.99 | 3.01 | 5.11 | Upgrade
|
| Change in Accounts Receivable | - | -39.23 | -24.83 | -46.04 | -6.3 | Upgrade
|
| Change in Inventory | - | -9.41 | -5.62 | -10.56 | -21.26 | Upgrade
|
| Change in Accounts Payable | - | 38.54 | -8.16 | 16.82 | 40.52 | Upgrade
|
| Change in Other Net Operating Assets | - | 5.5 | 6.87 | 5.79 | 7.87 | Upgrade
|
| Operating Cash Flow | - | 69.25 | 57.95 | 111.62 | 114.63 | Upgrade
|
| Operating Cash Flow Growth | - | 19.49% | -48.08% | -2.62% | 3478.75% | Upgrade
|
| Capital Expenditures | - | -120.86 | -77.55 | -146.96 | -105.98 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | 6.78 | - | Upgrade
|
| Cash Acquisitions | - | - | 0.02 | - | - | Upgrade
|
| Investment in Securities | - | -253.73 | -73.26 | -283.28 | -38 | Upgrade
|
| Other Investing Activities | - | 4.05 | 1.25 | 37.87 | 3.99 | Upgrade
|
| Investing Cash Flow | - | -370.54 | -149.53 | -385.59 | -139.99 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 32.34 | 42.82 | Upgrade
|
| Long-Term Debt Repaid | - | -11.3 | -45.42 | -62.79 | -21.6 | Upgrade
|
| Net Debt Issued (Repaid) | - | -11.3 | -45.42 | -30.45 | 21.22 | Upgrade
|
| Issuance of Common Stock | - | - | - | 1,523 | - | Upgrade
|
| Repurchase of Common Stock | - | -37.25 | -13.75 | - | - | Upgrade
|
| Common Dividends Paid | - | -51.22 | -73.83 | -2.08 | -1.8 | Upgrade
|
| Other Financing Activities | - | 0.13 | - | -15.74 | 0.2 | Upgrade
|
| Financing Cash Flow | - | -99.64 | -133.01 | 1,474 | 19.62 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 2.42 | 0.95 | 2.35 | -0.24 | Upgrade
|
| Net Cash Flow | - | -398.51 | -223.64 | 1,203 | -5.99 | Upgrade
|
| Free Cash Flow | - | -51.61 | -19.59 | -35.34 | 8.64 | Upgrade
|
| Free Cash Flow Margin | - | -17.36% | -8.06% | -12.01% | 4.06% | Upgrade
|
| Free Cash Flow Per Share | - | -0.44 | -0.17 | -0.35 | 0.10 | Upgrade
|
| Cash Income Tax Paid | - | 29.9 | 11.38 | 28.47 | 13.42 | Upgrade
|
| Levered Free Cash Flow | - | -48.83 | -38.18 | -100.94 | -34.34 | Upgrade
|
| Unlevered Free Cash Flow | - | -46.88 | -36.16 | -97.83 | -31.35 | Upgrade
|
| Change in Working Capital | - | -5.37 | -32.64 | -34.44 | 20.7 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.